Comparing the Efficacy and Safety of Apixaban Versus Warfarin in Morbidly Obese Patients

This study was conducted to evaluate the efficacy and safety of apixaban versus warfarin in morbidly obese patients. A total of 250 morbidly obese patients with a body mass index (BMI) higher than 40 kg/m(2) or a body weight higher than 120 kg who were on anticoagulation therapy with either apixaban...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Sultan N, Hasan, Hani, Metwali, Hend, Aseeri, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659312/
https://www.ncbi.nlm.nih.gov/pubmed/36407232
http://dx.doi.org/10.7759/cureus.30303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659312/
https://www.ncbi.nlm.nih.gov/pubmed/36407232
http://dx.doi.org/10.7759/cureus.30303

Ejemplares similares